Evidence map›Paper›PMID 38774070›Full record

ArticleHeliyon2024

Establishment of reference values based on influential characteristics of hematopoietic stem cells and immune cell subsets in the bone marrow.

Rebar N Mohammed, Najmaddin S H Khoshnaw, Vian Faeq Mohammed, Dastan O Hassan, Chra Nawfal Abdullah, Tavan Ismael Mahmood, Huda A Abbass, Dereen Ahmed, Kani D Noori, Lanja I Saeed and 6 more

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rebar N MohammedDepartment of Medical Laboratory Technology, Faculty of Health Science, Qaiwan International University, Sulaimani, Kurdistan Region, Iraq.
Najmaddin S H KhoshnawDepartment of Medical Laboratory Science, College of Science, Komar University of Science and Technology, KRG, Iraq.
Vian Faeq MohammedBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Dastan O HassanBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Chra Nawfal AbdullahBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Tavan Ismael MahmoodBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Huda A AbbassBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Dereen AhmedBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Kani D NooriBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Lanja I SaeedBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Salah Mohammed SalihBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Hiwa S SidiqBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Dlnya Omer AliBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Alan ShwanBone Marrow Transplant Center, Hiwa Hospital, Sulaymaniyah, KRG, Iraq.
Ignazio MajolinoOspedale San Camillo and Salvator Mundi International Hospital, Rome, Italy.
Francesco IpsevichOspedale San Camillo and Salvator Mundi International Hospital, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic stem cell transplantation is still a curative treatment for many haematological cancers. Many factors, such as age, sex, ethnic background, smoking status, and body mass index, affect average reference values in different populations. This study aimed to establish a reference range for the absolute numbers and percentages of healthy individuals' hematopoietic stem cells and immune cells in the bone marrow. Seventy-one healthy donors (32 males and 39 females) were enrolled in the study. Following bone marrow harvesting, using flow cytometry, immunophenotyping was performed to determine the absolute number and percentage of CD34

Indexed as

Bone marrow graftHealthy donorHSCImmune cellsReference range

Identifiers

PMID38774070
PMCPMC11107188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.